2,3 Dimercapto-1-propanol inhibits HIV-1 tat activity, viral production, and infectivity in vitro

We have examined the effect of 2,3 dimercapto-1-propanol (DMP), which is known as an anti-heavy metal-poisoning drug, against human immunodeficiency virus type 1 (HIV-1). We demonstrate that DMP inhibited transactivation directed by tat protein, which is a metal containing transcriptional transactivating factor and also interfered with viral production. Furthermore, treatment and pretreatment of cells with DMP strongly reduced their sensitivity for HIV-1 Infection through unknown mechanisms. These results indicate that DMP reveals pleuripotent effects on HIV-1 Infection and production in vitro and thus may provide an exploitable hypothesis for designing new drugs against AIDS.